Clinical Trials Manager Settles SEC Insider Trading Suit
A former Neuralstem Inc. clinical trials manager tipped her partner to bad company news, allowing him to avoid over $103,000 of investment losses, the U.S. Securities and Exchange Commission said Monday,...To view the full article, register now.
Already a subscriber? Click here to view full article